Links to Studies

Status Official Title Lead Investigator Last Updated
Finalised EPID Multiple Sclerosis Pregnancy study - Pregnancy outcomes in Multiple Sclerosis populations exposed and unexposed to interferon beta - a register-based study in the Nordic countries Dr Massoud Toussi 17/05/2022
Finalised A retrospective nationwide cohort study to investigate the treatment of type 2 diabetic patients in Finland - DAHLIA Dr Fabian Hoti 11/03/2021
Finalised A Population-based Cohort Study of Pregabalin to Characterize Pregnancy Outcomes Professor Vera Ehrenstein 25/08/2020
Finalised Drug utilization study of mirabegron (Betmiga®) using real-world healthcare databases from the Netherlands, Spain, United Kingdom and Finland Dr Ron Herings 02/05/2019
Finalised Realization of the clinical practice guidelines for diabetes in Finland – A case study of the usability of electronic patient information systems and national registers to support evidence based decision making in health care Dr Pasi Korhonen 11/12/2018
Finalised Incidence of Second primary MAlignancies in pRostate Cancer patients with bOne metastases – an observational retrospective cohort study in Sweden (SMARCOS) Dr Bayer Clinical Trials Contact Bayer AG 06/12/2018
Finalised A multinational active safety surveillance study of crizotinib in Europe Professor Henrik Toft Sørensen 18/07/2018
Finalised Pan European Multi-Database Bladder Cancer Risk Characterisation Study Dr Pasi Korhonen 30/05/2017
Finalised Pioglitazone Use and Risk of Bladder Cancer: a Systematic Review and Meta-Analysis of Observational Studies Dr Pasi Korhonen 27/04/2017
Finalised Risk of stroke and other cardiovascular events among warfarin-treated atrial fibrillation patients – a nationwide cohort study in Finland Dr Pasi Korhonen 25/04/2017
Finalised Assessment of association between severe hypoglycaemia and use of detemir, glargine and NPH insulins (ER11-9417/ U1111-1120-7164) Dr Jari Haukka 18/08/2016
Finalised The risk of developing prostate cancer in entacapone and levodopa/DDCI users compared to levodopa/DDCI users without entacapone - A nation-wide retrospective register-based study Dr Pasi Korhonen 17/08/2016
Ongoing Post-authorisation safety study to assess the risk of urinary tract malignancies in relation to empagliflozin exposure in patients with type 2 diabetes: a multi-database European study Dr Fabian Hoti 16/08/2022
Ongoing Multi-country non-interventional study on the effectiveness and safety of Empagliflozin in adult patients with type 2 diabetes in Europe and Asia Dr Fabian Hoti 03/02/2022
Ongoing Extrapyramidal symptoms in patients treated with Abilify Maintena®: Cohort study with a 2-year follow-up using European automated healthcare databases Dr Non-interventional Research Manager H. Lundbeck A/S 01/09/2020
Ongoing An Observational Post-Authorization Safety Study (PASS) of MOVENTIG® (Naloxegol) Drug Utilization in Selected European Populations Dr Javier Cid 14/02/2017
Planned A non-interventional study to examine patient characteristics Ms Novartis Clinical Disclosure Officer 05/05/2021
Planned Patient characteristics and cardiovascular and mortality outcomes in patients with type 2 diabetes mellitus initiating treatment with sodium-glucose co-transporter-2 inhibitors and other antidiabetic medications in Finland Dr Fabian Hoti 11/03/2021